文献速递头颈部肿瘤放疗放疗物理与技术

头颈部横纹肌肉瘤放疗后面部骨骼形态的剂量效应分析

Dose-effect analysis of facial bone morphology following radiation therapy for head and neck rhabdomyosarcoma.
PubMed 文献 · Radiother Oncol · 2026-03-31

结果显示面部变形者相应骨结构平均剂量显著更高,筛上颌复合体28GyEQD2起风险增加、51GyEQD2达50%变形概率,下颌复合体26GyEQD2起风险增加、41GyEQD2达50%概率。

要点

  • 面部变形幸存者对应骨结构平均剂量显著更高(p<0.001)。
  • 筛上颌复合体28GyEQD2起变形风险增加,51GyEQD2达50%概率。
  • 下颌复合体26GyEQD2起变形风险增加,41GyEQD2达50%概率。

核心结论

  • 研究给出了影响儿童头颈部横纹肌肉瘤幸存者面容的特定面部骨骼剂量阈值,有助于优化放疗计划以减少面部变形这一晚期不良反应。

主要发现

  • 面部变形幸存者相应骨结构的平均剂量显著高于无变形者(p<0.001)。
  • 筛上颌复合体28GyEQD2起面部变形易感性增加,51GyEQD2时生长变形概率为50%。
  • 下颌复合体26GyEQD2起生长变形概率增加,41GyEQD2时概率为50%。
  • 各面部骨骼变形风险增加的阈值范围为26GyEQD2至43GyEQD2,50%变形概率范围为44GyEQD2至55GyEQD2。

临床怎么用

  • 放疗计划设计时可参考特定面部骨骼的剂量阈值,以降低幸存者面部变形风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: With the long-term survival of paediatric rhabdomyosarcoma patients improving, the impact of late adverse effects becomes more important. These late effects in head-neck-rhabdomyosarcoma survivors include poor cosmesis associated with facial deformation. This study aims to correlate facial deformation with radiation dose and to propose new dose-effect models. MATERIALS AND METHODS: We evaluated 3D facial images of children treated with radiotherapy enrolled in our multi-center cross-sectional study with a primary head-neck-rhabdomyosarcoma. Facial deformation was calculated from 3D image analysis at follow-up and compared to a healthy control population (n = 537). The radiation dose delivered to all individual facial bones and sutures was extracted from original radiotherapy plans. Dose-effect probability curves were constructed by converting the dose to its equivalent 2 Gy/fraction EQD2 using binary logistic regression. RESULTS: Thirty-four survivors with a median follow-up of 9.2 years were included. Survivors with facial deformation all received significantly higher mean doses to the corresponding bony structures (p < 0.001). The ethmo-maxillary complex shows increased susceptibility for facial deformation at 28GyEQD2 and a 50% probability of growth deformation at 51GyEQD2. The mandibular complex shows increased growth deformation probability at 26GyEQD2 and a 50% probability at 41GyEQD2. The threshold for increased risk of bone deformation for individual facial bones varied from 26 GyEQD2 to 43 Gy EQD2 and a 50% probability for deformation varied from 44 Gy EQD2 to 55 Gy EQD2. CONCLUSION: Dose thresholds for specific facial bones impacting cosmesis in survivors of paediatric sarcoma are shown. These data are essential to improve treatment planning thereby limiting the debilitating late adverse effect of facial deformation.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Hol MLF, Suttie M, Gaze MN, et al. Dose-effect analysis of facial bone morphology following radiation therapy for head and neck rhabdomyosarcoma. Radiother Oncol. 2026. PMID: 41933593. doi:10.1016/j.radonc.2026.111492

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。